Display options
Share it on

Dig Dis Sci. 1995 Oct;40(10):2250-8. doi: 10.1007/BF02209015.

Changes in substance P-immunoreactive innervation of human colon associated with ulcerative colitis.

Digestive diseases and sciences

U Keränen, T Kiviluoto, H Järvinen, N Bäck, E Kivilaakso, S Soinila

Affiliations

  1. Second Department of Surgery, Helsinki University Central Hospital, Finland.

PMID: 7587798 DOI: 10.1007/BF02209015

Abstract

The amount of colonic substance P and substance P-receptors is increased in ulcerative colitis, which may denote that substance-P is involved as a neurogenic mediator in the inflammatory process of ulcerative colitis. We studied the anatomical distribution of elevated colonic substance P in ulcerative colitis and assessed morphometrically whether the changes in substance P correlate with alterations in colonic innervation. Full-thickness specimens of colonic wall were obtained from normal human colons (N = 9) and the most and least affected regions of ulcerative colitis colons (N = 10) and immunostained for substance P. Substance P immunoreactivity index was calculated by multiplying each intensity value by the number of pixels exhibiting this intensity value. The numbers of substance P-immunoreactive nerve fibers in the lamina propria were markedly increased, and their fluorescence intensity was enhanced in ulcerative colitis. The longitudinal muscle layer contained substance P-immunoreactive nerve fibers in ulcerative colitis, but not in the controls. The substance P-immunoreactive index (= number x intensity of nerve fibers) was 3.42 +/- 1.49 in controls, 21.19 +/- 7.79 in mild ulcerative colitis regions (P < 0.05), and 29.68 +/- 9.81 in severe ulcerative colitis regions (P < 0.01). Increase in the number of substance P nerve fibers is in accordance with the hypothesis that substance P contributes to neurogenic mediation of inflammation in ulcerative colitis.

References

  1. Gut. 1964 Feb;5:1-22 - PubMed
  2. Gastroenterology. 1983 Apr;84(4):777-86 - PubMed
  3. Dig Dis Sci. 1987 Apr;32(4):369-76 - PubMed
  4. Gastroenterology. 1988 Jul;95(1):32-41 - PubMed
  5. Dig Dis Sci. 1989 May;34(5):754-7 - PubMed
  6. Gastroenterology. 1984 Mar;86(3):421-35 - PubMed
  7. Gastroenterology. 1990 Sep;99(3):666-75 - PubMed
  8. Histochemistry. 1982;76(3):413-20 - PubMed
  9. Nature. 1985 May 2-8;315(6014):61-3 - PubMed
  10. Proc Finn Dent Soc. 1992;88 Suppl 1:73-82 - PubMed
  11. Peptides. 1990 Sep-Oct;11(5):879-94 - PubMed
  12. Peptides. 1985;6 Suppl 2:107-11 - PubMed
  13. Naunyn Schmiedebergs Arch Pharmacol. 1979 Dec;310(2):175-83 - PubMed
  14. Neuroscience. 1985 Sep;16(1):1-32 - PubMed
  15. Adv Exp Med Biol. 1991;298:253-83 - PubMed
  16. Dig Dis Sci. 1988 Mar;33(3 Suppl):41S-49S - PubMed
  17. J Invest Dermatol. 1990 Apr;94(4):492-5 - PubMed
  18. Gut. 1963 Dec;4:299-315 - PubMed
  19. J Invest Dermatol. 1991 Apr;96(4):434-8 - PubMed
  20. J Rheumatol. 1985 Jun;12(3):406-11 - PubMed
  21. Gastroenterology. 1992 Sep;103(3):840-7 - PubMed
  22. J Invest Dermatol. 1989 Jan;92(1):126-9 - PubMed
  23. Histochemistry. 1975;41(4):373-5 - PubMed
  24. Proc Natl Acad Sci U S A. 1988 May;85(9):3235-9 - PubMed
  25. J Anat. 1989 Oct;166:7-22 - PubMed
  26. Peptides. 1989 May-Jun;10(3):627-45 - PubMed
  27. Gastroenterology. 1986 Sep;91(3):746-68 - PubMed
  28. Neuroscience. 1981;6(10):1923-34 - PubMed
  29. Gastroenterology. 1992 Feb;102(2):461-7 - PubMed
  30. Exp Neurol. 1980 Jul;69(1):196-201 - PubMed
  31. Gut. 1991 Jan;32(1):61-5 - PubMed

Substances

MeSH terms

Publication Types